2-Week Study In People With Nonalcoholic Fatty Liver Disease

NCT03513588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-alcoholic Steatohepatitis
Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Placebo
DRUG: PF-06865571
DRUG: PF-06865571

Sponsor

Pfizer